Novo Nordisk plans to unlock the full potential of #EFX potentially as a #monotherapy or in combination with #Wegovyto address one of the most critical #obesity-related comorbidities of our time
Dietary lipid infusion causes the release of chole-cystokinin, which acts both via vagus nerve afferents and directly in the brain to trigger activation of efferent vagus nerve signalling, which in turn suppresses the release of proinflammatory cytokines
In addition, we cannot guarantee availability of an internet connection at all times
(Learn more about how GLP-1 medications work.) Slow-moving food can lead to an achy stomach or even vomiting
Deterministic and scenario analyses further demonstrated that the results were most sensitive to assumptions regarding treatment duration, time horizon, discounting, and the costs of diabetes-related complications
Insert the pen into your skin and hold down the dose button until it clicks or reaches 0